CLOVER BIO appoints Nicholas Jackson as President of Global R&D and Strategic Alliances
CLOVER BIO announced the appointment of Nicholas Jackson as President of Global R&D and Strategic Alliances. Nicholas Jackson will work closely with the company's CEO Liang Guo to accelerate the development of CLOVER BIO's combined vaccine candidate RSV+hMPV±PIV3
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments